Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?

por Alonso, Daniel F., Farina, Hernán G.
Publicado 2020

Cancer Antigen Prioritization: A Road Map to Work in Defining Vaccines Against Specific Targets. A Point of View

por Gomez, Daniel E., Vázquez, Ana María, Alonso, Daniel F.
Publicado 2012

AZT as a telomerase inhibitor

por Gomez, Daniel E., Armando, Romina G., Alonso, Daniel F.
Publicado 2012

Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

por Ripoll, Giselle V., Pifano, Marina, Garona, Juan, Alonso, Daniel F.
Publicado 2020

Anti-idiotype antibodies in cancer treatment

por Gomez, Daniel E., Vázquez, Ana M., Alonso, Daniel F., Macías, Amparo
Publicado 2013

Vasopressin Analog [V(4)Q(5)]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models

por Sobol, Natasha T., Solerno, Luisina M., Llavona, Candela, Alonso, Daniel F., Garona, Juan
Publicado 2023

Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

por Gabri, Mariano R, Otero, Laura L, Gomez, Daniel E, Alonso, Daniel F
Publicado 2009

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System

por Blanco, Rancés, Rengifo, Enrique, Cedeño, Mercedes, Rengifo, Charles E., Alonso, Daniel F., Carr, Adriana
Publicado 2011

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells

por Pifano, Marina, Garona, Juan, Capobianco, Carla S., Gonzalez, Nazareno, Alonso, Daniel F., Ripoll, Giselle V.
Publicado 2017

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell l...

por Segatori, Valeria I., Vazquez, Ana M., Gomez, Daniel E., Gabri, Mariano R., Alonso, Daniel F.
Publicado 2012

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model

por Ripoll, Giselle V., Garona, Juan, Pifano, Marina, Farina, Hernan G., Gomez, Daniel E., Alonso, Daniel F.
Publicado 2013

Preclinical Efficacy of [V(4)Q(5)]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer

por Garona, Juan, Sobol, Natasha T., Pifano, Marina, Segatori, Valeria I., Gomez, Daniel E., Ripoll, Giselle V., Alonso, Daniel F.
Publicado 2019

Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3

por Guthmann, Marcelo D., Venier, Cecilia, Toledo, Darien, Segatori, Valeria I., Alonso, Daniel F., Fainboim, Leonardo, Vázquez, Ana M., Ostrowski, Hector
Publicado 2013

Telomere structure and telomerase in health and disease

por GOMEZ, DANIEL E., ARMANDO, ROMINA G., FARINA, HERNÁN G., MENNA, PABLO LORENZANO, CERRUDO, CAROLINA S., GHIRINGHELLI, P. DANIEL, ALONSO, DANIEL F.
Publicado 2012

Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy

por Solernó, Luisina M., Sobol, Natasha T., Gottardo, María F., Capobianco, Carla S., Ferrero, Maximiliano R., Vásquez, Liliana, Alonso, Daniel F., Garona, Juan
Publicado 2022

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization

por Gottardo, Maria F., Capobianco, Carla S., Sidabra, Johanna E., Garona, Juan, Perera, Yasser, Perea, Silvio E., Alonso, Daniel F., Farina, Hernan G.
Publicado 2020

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

por Fernandez, Luis E., Gabri, Mariano R., Guthmann, Marcelo D., Gomez, Roberto E., Gold, Silvia, Fainboim, Leonardo, Gomez, Daniel E., Alonso, Daniel F.
Publicado 2010

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides – preclinical and clinical data

por Vázquez, Ana M., Hernández, Ana M., Macías, Amparo, Montero, Enrique, Gómez, Daniel E., Alonso, Daniel F., Gabri, Mariano R., Gómez, Roberto E.
Publicado 2012

Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

por Cardama, Georgina A, Gonzalez, Nazareno, Ciarlantini, Matias, Gandolfi Donadío, Lucia, Comin, María Julieta, Alonso, Daniel F, Menna, Pablo Lorenzano, Gomez, Daniel E
Publicado 2014

Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines

por Cardama, Georgina A, Comin, Maria J, Hornos, Leandro, Gonzalez, Nazareno, Defelipe, Lucas, Turjanski, Adrian G, Alonso, Daniel F, Gomez, Daniel E, Menna, Pablo Lorenzano
Publicado 2014